ICICI Prudential Mutual Fund, which previously held a 2.34 percent stake in Procter & Gamble Health Limited, is no longer listed among the company's disclosed shareholders, indicating either a complete exit or a reduction in their holding below the 1 percent reporting threshold.
A pharmaceutical manufacturer and marketer, P&G Health Ltd produces medicines and chemical products for domestic and international markets. The company operates across multiple therapeutic areas, focusing on both prescription and over-the-counter medications. Its operations span manufacturing facilities, research capabilities, and an established distribution network across India. The company serves healthcare providers and consumers through a diverse product portfolio.
India's second-largest AMC by AUM with over Rs 9 lakh crore managed across 80+ schemes. Joint venture between ICICI Bank and Prudential plc. CIO S. Naren is one of India's most recognised value investors, known for contrarian macro calls and rotating across market caps well ahead of consensus. ICICI Pru's quarterly portfolio disclosures are among the most closely watched in the industry.
